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We constructed alphavirus vectors encoding the ecotropic murine leukemia virus (MLV) receptor mCAT1. Cells electro-
porated with these vector RNAs expressed mCAT1 protein and fused with cells that expressed a fusogenic form of the MLV
envelope on the cell surface. Electroporated cells also released submicron particles that were infectious in envelope-
expressing cells. Infection resulted in giant syncytia that could be enumerated by plaque assay. Cell-free supernatants could
be serially passaged and contained up to 104 infectious units/ml. To determine whether repeated passage would select for
functional variants of the receptor, we analyzed mCAT1 amplified by RT-PCR after 12 serial passages. Several amino acid
substitutions were identified that encoded functional receptor variants. In independent experiments, variants containing an
isoleucine or a leucine instead of a phenylalanine at position 224 in the third extracellular domain of the receptor arose
spontaneously and outgrew the parental vector, indicating that mutations at this site are highly selected in this system. This
region of the receptor has previously been implicated in the envelope–receptor interaction. This alphavirus vector system
provides a novel method for generating and selecting functional variants of viral receptors © 2000 Academic Press
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lINTRODUCTION
Expression vectors have been made from alphavi-
ruses by substituting genes of interest for alphavirus
structural genes (Xiong et al., 1989; Liljestrom and Garoff,
1991). The alphavirus genome consists of a single-
stranded RNA ;12 kb long, the first two thirds of which
encodes an enzyme complex that replicates viral RNA
via a negative-strand intermediate (Strauss and Strauss,
1994). Transcription of the virus negative strand results in
full-length genomic RNA as well as a subgenomic, pos-
itive-strand RNA corresponding to the 39 end of the
genome that encodes capsid and envelope. Substitution
of other genes for capsid-envelope yields vectors that,
when introduced as RNA into susceptible cells, go
through one round of RNA amplification and produce
large amounts of the substituted gene product. These
vectors do not spread between cells due to the absence
of virus structural proteins.
In 1994, Rolls et al. (1994) observed that an alphavirus
vector encoding vesicular stomatitis virus envelope gly-
coprotein (VSV-G) could spread in tissue culture, despite
the absence of alphavirus structural proteins, due to
fusogenic activity of VSV-G protein. Sonicates of vector-
containing cells were capable of initiating new rounds
infection. Supernatants of infected cells also contained
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124infectious particles, with titers of ;104 infectious units/
l. The infectivity was resistant to RNase, sensitive to
etergent, could be filtered (,0.45 mm), banded in su-
rose, and neutralized by anti-VSV-G antiserum, suggest-
ng that it consisted of membranous vesicles with VSV-G
rotein on the outside and vector RNA on the inside.
ecause the infectious particles lacked capsid, they
ere dubbed “primitive viruses.” Spontaneous release of
nfectious vesicles could have been related to cytopath-
city of VSV-G protein or the alphavirus replicon, which
huts off host cell synthesis and leads to cell death in
–3 days. We observed that alphavirus vectors encoding
fusogenic form of MLV envelope also generated infec-
ious vesicles that could be passaged like viruses in
ells expressing the cognate receptor (Lebedeva et al.,
997).
Given the apparent structural simplicity of these prim-
tive viruses, we wondered whether the roles of envelope
nd receptor could be switched (i.e., if vectors encoding
irus receptor could generate vesicles capable of infect-
ng cells expressing virus envelope on their surface). In
rhabdovirus vector system, vectors encoding CD4 plus
IV coreceptor were reported to make particles that
ere infectious specifically for cells bearing HIV enve-
ope (Schnell et al., 1997; Mebatsion et al., 1997). MLV
vectors encoding retroviral receptors instead of MLV
envelope were also recently shown to be infectious for
cells expressing the cognate envelope (Baillet and
Bates, 1998). The receptor for the ecotropic class of MLV
125CHANGES IN A RETROVIRAL RECEPTOR DURING PASSAGEis a cell surface protein that normally functions as a
cationic amino acid transporter, mCAT1 (Albritton et al.,
1989; Kim et al., 1991; Wang et al., 1991). We constructed
alphavirus vectors encoding mCAT1 and investigated
their ability to spread infection in cells expressing MLV
envelope. We found that such vectors could be serially
passaged as cell-free supernatants and that serial pas-
sage was associated with selection of functional variants
of the receptor. This represents a novel system for gen-
erating and selecting functional variants in virus recep-
tors.
RESULTS
Vectors encoding an MLV receptor are infectious in
cells expressing a fusogenic form of MLV envelope
MLV envelope is synthesized as a nonfusogenic pre-
cursor that is activated by cleavage of 16 amino acids
from the cytoplasmic tail of its transmembrane (TM)
segment (Ragheb and Anderson, 1994; Rein et al., 1994).
This cleavage, which is normally effected by the viral
protease late in the process of virus budding, produces
a 12-kDa form of TM (“p12e”) (Schultz and Rein, 1985).
The predominant form of envelope on the surface of
infected cells is the immature, nonfusogenic form. We
previously showed that wild-type MLV envelope ex-
pressed from an alphavirus vector was not fusogenic
because it did not undergo the activating cleavage of its
cytoplasmic tail, whereas MLV envelope truncated by
virtue of a stop codon at the site of the cytoplasmic tail
cleavage site was fusogenic (Lebedeva et al., 1997).
BHK cells electroporated with a Sindbis vector encod-
ing the MLV receptor mCAT1 (Fig. 1, line 1) formed
syncytia when cocultivated with BHK cells electropo-
rated with vectors encoding the truncated MLV envelope.
They did not form syncytia when cocultivated with cells
expressing the full-length, immature envelope on the cell
surface such as NIH3T3 cells chronically infected with
MLV and BHK cells electroporated with vectors encoding
the full-length MLV envelope. Similar results were ob-
tained with Semliki Forest virus vectors encoding mCAT1.
To determine whether cells electroporated with alpha-
virus vectors encoding mCAT1 produced infectious ves-
icles, we first constructed target cells that stably ex-
pressed the fusogenic form of MLV envelope on their
surface. We transfected BHK cells with a stable expres-
sion plasmid pMLVenv12 (Fig. 1, line 3) and selected
G418-resistant colonies. Colony cells were tested for
expression of MLV envelope by flow cytometry using an
antiserum to MLV envelope. Several MLV envelope pos-
itive clones were established; one used in subsequent
experiments is designated BHK-MLVenv12. BHK-MLV-
env12 cells formed syncytia when cocultivated with cells
expressing mCAT1 (XC cells, NIH3T3 cells, and BHK
cells electroporated with alphavirus vectors encoding
mCAT1). They did not form syncytia with mCAT1-negativecells, including BHK cells and MLV-NIH3T3 cells, in
which the mCAT1 receptor is absent from the cell surface
due to chronic infection with MLV.
BHK-MLVenv12 cells were then used as an indicator
cell line to assay for infectious particles capable of di-
recting the synthesis of mCAT1. To determine whether
BHK cells electroporated with the Sindbis mCAT1 vector
could make such particles, we disrupted these cells by
Dounce homogenization, sonication, or vigorous shaking
with glass beads; filtered the material through 0.45-mm
filters; and infected BHK-MLVenv12 cells with the filtrate.
Syncytia appeared after ;8 h, the time required for
alphavirus vectors to replicate and express passenger
genes (Garoff and Li, 1998). Syncytia gradually increased
in size until they were nearly 1 mm in diameter at 48–72
h (Fig. 2B), after which they began to slough. This time
course suggests that newly synthesized mCAT1 protein
was responsible for syncytia rather than mCAT1 protein
in the inoculum. The three disruption methods produced
approximately equal titers: ;104 to 105 syncytia-forming
units/ml. The infectious inocula did not produce syncytia
on plain BHK cells (Fig. 2C), NIH3T3 cells, or MLV-
NIH3T3 cells, which express the full-length MLV enve-
lope. As a further control, we made NIH3T3 cells stably
expressing the truncated, fusogenic MLV envelope. Be-
cause plain NIH3T3 cells die when transfected with
pMLVenv12, presumably because they fuse with neigh-
FIG. 1. Schematic diagram of plasmid constructs. Nonrelevant por-
tions of plasmids are omitted. The first two lines show the structure of
plasmids from which alphavirus vector RNA was synthesized in vitro.
SP6pr denotes the SP6 RNA polymerase promoter used for RNA syn-
thesis; replicase, the alphavirus nonstructural genes that recognize
and replicate virus-related RNA in vivo; SGpr, the alphavirus sub-
genomic promoter, which determines the 59 end of subgenomic viral
RNAs; mCAT1, the ecotropic MLV receptor; An, 39 poly(A)
1 tract en-
coded in the vector just upstream of the vector linearization site; lacZ,
b-galactosidase; and MLVenv12, fusogenic form of MLV envelope with
a stop codon at the normal p12e cleavage site. The last line shows the
structure of the DNA expression plasmid used to make indicator BHK
cells stably expressing the fusogenic form of MLVenv. TKpr denotes
thymidine kinase promoter; neo, G418 resistance gene; CMVenh/CApr,
CMV immediate-early enhancer followed by a chicken actin promoter;
and stop, stop codon inserted at the end of MLV env p12e. Restriction
sites: M, MluI; B, Bsp120I; P, PacI; X, XbaI; Bg, BglII, Av, AvaI; and C, ClaI.boring cells expressing mCAT1, we used MLV-infected
NIH3T3 cells in which the mCAT1 receptor is down-
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126 KAZACHKOV ET AL.regulated. MLV-NIH3T3 cells were transfected with pM-
LVenv12 and selected with G418, yielding a clone desig-
nated MLV-NIH3T3-MLVenv12. These cells formed syn-
cytia when infected with sonicates from BHK cells
electroporated with SINmCAT1 vectors. Thus syncytia
formation by the SINmCAT1 sonicates were specific for
cells expressing the fusogenic envelope.
Growth kinetics of CAT1 infectious vectors on MLV
envelope-expressing cells
FIG. 2. Syncytia and plaque assay. Low-power photomicrographs of c
A-C) The fields of view are ;1 3 2 mm. (A) Uninfected BHK-MLVenv12 c
electroporated with pSINmCAT1 RNA. (C) BHK cells infected with the
infected with 1 ml, 100 ml, or 10 ml, respectively, of infectious material
m.BHK-MLVenv12 cells were infected with 0.5 ml of fil-
tered sonicate from BHK cells electroporated with pSIN-
u
imCAT1. Four hours after infection, the inoculum was
replaced with fresh medium. Supernatants and cells
from replicate dishes were collected at various times
thereafter. The supernatants were filtered (0.45 mm), and
he cells were sonicated in 1 ml of medium and then
iltered (0.45 mm). The filtrates were assayed for syncytia-
nducing units on BHK-MLVenv12 cells. Figures 2D–2F
rovide an example of the plaque assay.
In the first experiment summarized in Table 1, an
noculum containing 650 syncytia-inducing units was
ined with carbol Fuchsin–methylene blue (see Materials and Methods).
) BHK-MLVenv12 cells infected with filtered supernatant from BHK cells
supernatant as in B. (D–F) Lower-power view of BHK-MLVenv12 cells
from pSINmCAT1 as in B. In D–F, the bar markings at the top are inells sta
ells. (B
samesed to infect BHK-MLVenv12 cells at a multiplicity of
nfection of ;1023. Lysates of these infected cells were
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127CHANGES IN A RETROVIRAL RECEPTOR DURING PASSAGEfirst detected to contain syncytia-inducing units 16 h after
infection, and the number of syncytia-inducing units in-
creased from 16 to 32 h after infection and then declined.
The decline was associated with an extensive cytopathic
effect in the producer cultures. The peak titer in the cell
lysate was 4 3 104 syncytia-inducing units/ml, which
ndicates that the culture produced more than 100 infec-
ious units for each input infectious unit. Syncytia-induc-
ng units also were detected in the supernatant, increas-
ng from 16 to 48 h after infection, with a peak of 4 3 104
infectious units/ml.
In the second experiment summarized in Table 1, the
inoculum contained 5000 syncytia-inducing units, ;10
times the previous dose. The titer in the cell lysate
peaked earlier, at 20 h, at 2.8 3 104 infectious units/ml.
pontaneously released infectious material was lower,
00 infectious units/ml, but as in the first experiment, it
ersisted for 48 h. The amount of spontaneously re-
eased infectivity has varied between experiments much
ore than the amount of cell-associated infectivity and
TABLE 1
Growth Kinetics of Infectious Vesicles
Material Hours after infection
Syncytia-inducing units
in indicated volume
0.1 ml 0.01 ml 0.001 ml
Cell lysate 4 0 0 0
8 0 0 0
16 TMTC 20 4
24 TMTC 70 13
32 TMTC 100 36
48 85 13 5
0.5 ml 0.05 ml 0.005 ml
Supernatant 8 1 1 0
16 28 8 1
24 76 9 3
32 TMTC 55 15
48 TMTC TMTC 200
Note. Experiment I: BHKenv12 cells were infected with 1 ml of filtered
cell lysate containing 659 syncytia-inducing units of SINmCAT1 vector.
Four hours later, the inoculum was replaced with 3 ml of DMEM.
Supernatants and cells were collected at the indicated times from
replicate dishes; cells were lysed in 3 ml of DMEM, and lysates and
supernatants were filtered (0.45 mm) and assayed for syncytia-inducing
nits on fresh BHK-MLVenv12 cells.
Hours postinfection 4 8 12 20 30 48
Cell homogenate titer (/ml) 10 1000 7000 28,000 5000 5000
Supernatant titer (/ml) 80 16 10 100 200 200
Note. Experiment II: BHK-MLVenv12 cells were infected with 5000
syncytia-inducing units and assayed as for experiment I.ay be sensitively related to the input titer, target cell
ensity, and degree of cytopathicity.election of CAT1 variants during serial passage
Alphavirus vectors mutate rapidly in tissue culture due
o low fidelity of the viral replicase plus selection for
ariants that replicate and/or spread faster (Strauss and
trauss, 1994). In vectors that contain passenger genes
ot required for spread or replication, the additional
enes are often rapidly lost (Pugachev et al., 1996; Rolls
t al., 1996). Therefore, we theorized that repeated pas-
age of the Sindbis-mCAT1 vector on BHK-MLVenv12
ells might result in the loss of portions of the mCAT1
ene that are not required for spread in this system or
eveal other mutations in the receptor that either were
eutral or facilitated spread.
As a preliminary test of this idea, we made a Semliki
ector encoding b- galactosidase followed by a dupli-
cated subgenomic promoter driving the fusogenic MLV
env (Lebedeva et al., 1997) (Fig. 1, line 2). RNA from this
vector induced b-galactosidase-positive syncytia in
IH3T3 cells. Sequential passage of filtered superna-
ants from these cells produced syncytia in NIH3T3 cells,
ut the proportion of syncytia that expressed b-galacto-
idase decreased from 54 of 54 (100%) on passage 1 to
8 of 112 (79%) on passage 2 to 64 of 104 (72%) on
assage 3 to 26 of 68 (38%) on passage 4 and 2 of 202
1%) on passage 5. Thus a gene for which there was no
election (b-galactosidase) was rapidly lost on passage
of infectious vector.
To determine what happened to the mCAT1 gene on
passage, after 12 serial passages of filtered superna-
tants, we amplified the ;2-kb mCAT1 insert by RT-PCR
and cloned the amplified product in the empty Sindbis
vector, pSinRep5. Sequencing the insert in three clones
revealed one in-frame deletion of three amino acids, two
silent base changes, nine base changes resulting in
amino acid substitutions in the coding sequence, as well
as three substitutions and one single base insertion in
the 39 noncoding region (Table 2). All three clones were
functional in terms of ability to induce syncytia and in-
fectious particles in electroporated BHK-MLVenv12 cells.
One of the changes, a T-to-A substitution at position 670
corresponding to a phenylalanine-to-isoleucine substitu-
tion at residue 224 in the third putative extracellular
domain of CAT1, was common to all three clones. This
region of mCAT1 has previously been implicated in the
envelope–receptor interaction (Albritton et al., 1993; Ka-
vanaugh et al., 1994; Kim and Cunningham, 1993; Yoshi-
moto et al., 1993; Eiden et al., 1993, 1994).
To determine whether these changes arose during
serial passage, rather than as artifacts of PCR, we made
use of the fact that some of the changes lead to the gain
or loss of a restriction site. This allowed us to analyze
bulk RT-PCR products from infected cells at various lev-
els of passage for the presence of the variant se-
quences. The phenylalanine-to-isoleucine change at
amino acid 224 corresponds to loss of a Tsp509I site at
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128 KAZACHKOV ET AL.position 667. Sequence variants lacking this Tsp509I site
ere detectable at passage 7 and had completely re-
laced the parental sequence by the 13th passage in
nfected cells (Fig. 3A, lane 2). Restriction enzyme poly-
orphisms corresponding to two other amino changes
312 Ile3 Met and 594 Phe3 Ser) were not detected in
the bulk RT-PCR products from infected cells, implying
that these changes were present in only a small fraction
of the passaged vector or that they were PCR artifacts
captured during cloning.
To determine whether the variant sequences con-
ferred a growth advantage, we electroporated BHK cells
with a 10:1 mixture of RNA from the original Sindbis
mCAT1 clone versus one of the clones lacking the
Tsp509I site (clone 1). In one experiment (Fig. 3A, lanes
4–7), the Tsp509I variant increased from low levels at
early passages to ;40% by passage 6. This pattern of
moderate increase in the proportion of sequences lack-
ing theTsp509I site was seen in a second competition
experiment, whereas in two other experiments the
Tsp509I variant was lost during serial passage. Loss of
the Tsp509I-negative variant in some experiments does
not rule out selective advantage, because vectors retain-
ing the Tsp509I site could have accrued other mutations
conferring selective advantage (see later).
Another way to evaluate the significance of the phe-
nylalanine-to-isoleucine change is to repeat the serial
passage and see whether the same change occurs. A
second serial passage was performed starting with the
TABLE 2
Nucleotide and Predicted Amino Acid Changes in mCAT1
after 12 Serial Passages.
Clone Nucleotide position Amino acid position
1a 670 T 3 A 224 Phe 3 Ile
1 1380 C 3 T 460 silent
1 1562 C 3 T 521 Ala 3 Val
1 1781 T 3 C 594 Phe 3 Ser
1 2090 insert C 39 noncoding
1 2153 C 3 T 39 noncoding
2 114 A 3 T 38 silent
2 299 A 3 G 100 Tyr 3 Cys
2a 670 T 3 A 224 Phe 3 Ile
2 790 T 3 C 264 Cys 3 Arg
2 851 T 3 C 284 Val 3 Ala
2 1875 A 3 G 39 noncoding
3a 670 T 3 A 224 Phe 3 Ile
3 936 C 3 G 312 Ile 3 Met
3 1283 A 3 G 428 Glu 3 Gly
3 1743–1751 deletion 582–584 (Phe-Ala-Val)del
3 1811 C 3 T 604 Ala 3 Val
3 1894 A 3 G 39 noncoding
Note. Position 1 5 first base of mCAT1 coding sequence.
a Common to all clones.wild-type pSINmCAT1 vector. At various passage levels,
RNA was isolated from cells, and a segment of mCAT1FIG. 3. Evolution of pSINmCAT1 RNA in vivo. Restriction fragment
polymorphism analysis of a 430-bp segment of the mCAT1 gene
containing the third extracellular loop. DNA was obtained by RT-PCR
from cloned plasmids or RNA from cells infected with serially pas-
saged pSINmCAT1. PCR products were digested with Tsp501I (A and
B) or BstUI (C), electrophoresed in acrylamide, and stained with
ethidium bromide. Panels A and B show the evolution of variant
sequences lacking a Tsp501I site, which results in a 257-bp frag-
ment, rather than 95- and 162-bp fragments. (A, lanes 1–3) Serial
passage beginning with wild-type vector; cellular RNAs for RT-PCR
were from the 7th, 13th, and 20th passages, respectively. Lanes 4–7,
a competition serial passage experiment beginning with a mixture of
90% wild-type–10% clone 1 vector RNA. RNAs were from the 3rd, 4th,
6th, and 7th passages, respectively. Lane 8, (dilute) 100-bp ladder.
Lanes 9–11, PCRs were from DNA from wild-type vector, clone 1, or
a 9:1 mixture of the two, respectively. Lane 12, 100-bp ladder marker.
(B) Repeat serial passage experiment beginning with wild-type vec-
tor. Lanes 1–6, RT-PCR began with cellular RNA from passages 1, 4,
7, 9, 13, and 14, respectively. Lanes 7 and 8, PCR began with DNA
from wild-type plasmid and clone 1, respectively. Lane 9, 100-bp
ladder marker. (C) Evolution of variant sequences gaining a BstUI
site from the same serial passage experiment shown in panel B.
Lanes 1–5, RT-PCR began with cellular RNA from passages 1, 4, 7, 9,
and 13, respectively. Lanes 6 and 7, PCR began with DNA from clone
containing BstUI site or wild-type vector, respectively. Lane 8,
100-bp ladder marker.
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129CHANGES IN A RETROVIRAL RECEPTOR DURING PASSAGEcontaining the third extracellular loop was amplified by
RT-PCR and analyzed by Tsp509I digestion. As shown in
Fig. 3B, the Tsp509I site was again lost in an increasing
proportion of passaged vector. RT-PCR products from the
12th passage were cloned, and three clones lacking the
Tsp509I site as well as six clones containing the Tsp509I
site were sequenced. All three clones lacking the
Tsp509I site were found to have a T-to-C change at base
670 corresponding to a phenylalanine-to-leucine substi-
tution at amino acid 224. Thus the phenylalanine was
replaced by leucine instead of isoleucine in the second
experiment. In addition, one of the clones had a C-to-T
change at position 761 corresponding to a threonine-to-
isoleucine substitution at amino acid 254. Interestingly,
all of the clones containing the wild-type Tsp509I se-
quence had a T-to-C change at position 698 correspond-
ing to a valine-to-alanine substitution at amino acid 233.
This T-to-C change at position 698 led to the gain of a
BstUI site. BstUI digestion of RT-PCR products from total
ell RNA at different passage levels showed that the
stUI variant constituted ;40% of the vector RNA at
assage 13 (Fig. 3C). Thus a large proportion of the
equence variants that retained the phenylalanine at
osition 224 were not actually “wild type” but had under-
one selection for another amino acid substitution in the
hird extracellular loop of mCAT1.
DISCUSSION
Our data show that alphavirus vectors encoding the
CAT1 receptor can spread in tissue culture in cells
xpressing a fusogenic form of MLV envelope. Thus the
henomenon of “minimal viruses” derived from alphavi-
us vectors encoding fusogenic proteins (Rolls et al.,
1994) can be extended to vectors encoding a viral recep-
tor instead of viral envelope. Although previous reports
showed that vectors encoding VSV-G protein and a trun-
cated, fusogenic form of MLV envelope lead to infectious
vesicles and spreading infection (Rolls et al., 1994; Leb-
edeva et al., 1997), it is important to point out that not all
viral envelopes and receptors lead to infectious particles
in this system. Semliki vectors encoding rabies virus
envelope spread poorly (Rolls et al., 1994), and we have
so far been unsuccessful in generating spreading infec-
tion with vectors encoding HIV env or CD4 plus CXCR4,
despite their ability to induce fusion in cells expressing
the cognate fusion proteins. What features are required
for spreading infection beyond cell surface expression
and the ability to induce fusion are, so far, unknown.
The appearance of infectious particles in the superna-
tant correlated roughly with the onset and extent of
cytopathic effect in infected BHK cells, suggesting that
infectious particle formation may be a relatively nonspe-
cific effect of cell degeneration. A low rate of cell degen-
eration with release of vesicles has been reported in
normal cell lines and is accelerated by apoptosis (Zhanget al., 1998). Sindbis vectors shut off host cell synthesis
and cause cytopathicity after 30–40 h (Frolov and
Schlesinger, 1994), which may be related to apoptosis
seen with full-length Sindbis virus (Nava et al., 1998;
Karpf and Brown, 1998; Joe et al., 1998). Sindbis RNA
replicates in association with cell membranes (Fro-
shauer et al., 1988), so cell fragmentation associated
with necrosis or apoptosis could release vesicles carry-
ing vector RNA. On the other hand, the production of
infectious vesicles cannot be solely a consequence of
Sindbis vector replication, because not all vector-en-
coded fusion proteins lead to infectious vesicles. The
ability of some vector-encoded fusion proteins to gener-
ate infectious particles could be related to their interac-
tion with cellular proteins or lipids normally involved in
vesicle formation. The mCAT1 protein colocalizes in the
plasma membrane with caveolin (McDonald et al., 1997),
a protein involved in vesicle formation and associated
with specialized lipid domains known as “rafts” (Li et al.,
1998; Reitveld and Simons, 1998).
We initially hoped that the alphavirus-mCAT1 vector
would provide a model for vectors that specifically infect
(and kill) retrovirus-infected cells. In the case of MLV, this
was not possible because chronically infected cells ex-
press the immature, nonfusogenic form of envelope on
their surface. The fact that cells bearing the immature
envelope were not susceptible to infection provides
strong evidence that infection in this system involves
fusion rather than just binding, which is mediated by the
SU portion of the MLV envelope. This contrasts with
recent studies in which Sindbis vectors were targeted to
various cells by inserting a segment of protein A into the
Sindbis E2 envelope gene and mixing mutant virus par-
ticles with IgG specific for target cell surface antigens
(Ohno et al., 1997). Curiously, the Sindbis E1 protein,
which mediates virus–cell fusion, was not detected in
these particles, raising the possibility that these vectors
entered cells via an alternative mechanism.
Passage of a gene like mCAT1 in alphavirus vectors
with continued selection for fusogenicity may be a good
way to search for functional variants in a receptor. The
rate of mutation of the CAT1 gene when inserted into the
alphavirus vector is orders of magnitude higher than
when inherited as a normal mouse gene. We found eight
amino acid changes in full-length clones of amplified
receptor after 12 serial passages and three more in
clones of a 430-bp segment containing the third extra-
cellular loop of mCAT1. Because we analyzed cloned
inserts amplified by RT-PCR, the possibility of RT or PCR
artifacts is of obvious concern. The fact that none of the
changes in the full-length clones abolished functionality
provides circumstantial evidence that the changes were
not artifacts. Also, the number of mutations we observed
is higher than expected for RT-PCR but consistent with
mutation rates of RNA polymerases: 16 nucleotide
changes (counting the 9-base deletion as one change) in
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130 KAZACHKOV ET AL.6 kb of sequenced DNA corresponds to an error rate of
2.7 3 1023, which is ;7 times higher than expected for
T (;1024) followed by 30 cycles of PCR with an error
rate of 1025/cycle. The observed rate of 2.7 3 1023 after
12 serial passages is consistent with the mutation rate of
many RNA polymerases (;1024) and the observation that
any RNA viruses propagate as a swarm of RNA qua-
ispecies (Eigen, 1993; Domingo and Holland, 1997).
Three of the mutations, the phenylalanine-to-leucine
nd -isoleucine changes at amino acid 224 and the
aline-to-alanine change at amino acid 233, could not
ave been artifacts because restriction analysis of bulk
T-PCR products showed that vectors with these se-
uences constituted a significant fraction of total vector
NA at several times during passage (Fig. 3). The loca-
ion of these changes fits with observations that residues
t nearby sites in the third extracellular loop of CAT1
ffect envelope binding and are responsible for differ-
nces in receptor function between homologues of
CAT1 (Albritton et al., 1993; Kavanaugh et al., 1994; Kim
nd Cunningham, 1993; Yoshimoto et al., 1993; Eiden et
l., 1993, 1994). The change from phenylalanine at posi-
ion 224 to leucine or isoleucine in independent experi-
ents argues strongly that changes at position 224 are
elected.
The reason for the selective advantage of some
CAT1 sequence variants in this system is not yet clear.
hey could lead to increased fusion between mem-
ranes containing envelope and receptor, or they could
ffect processes specific to the Sindbis vector system
uch as formation of vector RNA-containing vesicles or
etails of cell-to-cell spread. We did not detect a differ-
nce in the titer of infectious vesicles or plaque size
hen we compared vectors encoding wild-type versus
ariant mCAT1 sequences, but these assays are not very
recise. We also failed to detect a difference in the titer
f MLV particles assayed on BHK cells chronically ex-
ressing the wild type versus a variant mCAT1 gene.
owever, a small increase in the rate of spread of a
ector encoding a variant mCAT1 gene could lead to a
arge increase in the relative amount of that vector after
ultiple cycles because of the exponential nature of
rowth. For alphavirus vectors, the cycle time could be
s short as 8 h, so 12 serial passages with growth for
4–48 h during each passage could represent more than
0 cycles.
This system may provide a useful method for gener-
ting diversity in viral receptor genes while maintaining
election for fusogenicity. The low titer of infectious ves-
cles in this system would appear to pose a limitation,
ecause it suggests that only a small number of muta-
ions would be screened in any experiment. However,
ost spread of vector in this system probably occurs
hrough cell–cell contact rather than the formation of
nfectious particles in the supernatant, and in this setting,
t is difficult to estimate the number of variant sequencesenerated and the number of such sequences exposed
o selection via expressed proteins. Empirically, finding
imilar mutations in 1 particular amino acid of 622 amino
cids in mCAT1 in independent experiments suggests
hat most single base mutations are probably sampled in
ach experiment and, remarkably, that the number of
trongly selected mutations is small. Two related sys-
ems have been reported in which receptor genes were
ubstituted for virus envelope genes in rapidly replicat-
ng vectors. In one, mCAT1 and an avian leukosis virus
eceptor were inserted into a retroviral vector and shown
o produce virus particles that infected cognate enve-
ope-expressing cells (Baillet and Bates, 1998). In the
ther, rhabdovirus vectors encoding HIV receptors were
sed to target HIV envelope-expressing cells (Schnell et
l., 1997; Mebatsion et al., 1997). Apart from their interest
s potential “magic bullets” to target virus-infected cells,
hese systems could be useful for identifying receptor
ariants with potentially useful properties such as al-
ered receptor binding.
MATERIALS AND METHODS
ectors
The vectors used in this study are shown schemati-
ally in Fig. 1. pSINmCAT1 was made by transferring a
.2-kb BamHI–StuI fragment containing the CAT1 gene
rom pJET (Albritton et al., 1989) to a BamHI–SmaI-di-
ested pGEM7Z plasmid (Promega, Madison, WI). The
CAT1 gene was cut out of this plasmid as an MluI–
sp120I fragment and transferred to pSinRep5 (InVitro-
en, Carlsbad, CA) cut with the same enzymes (Fig. 1,
irst line).
pSFVlacZ-MLVenv12 is a double subgenomic pro-
oter Semliki Forest virus vector containing lacZ after
he 59 subgenomic promoter and MLV envelope with a
top codon at the normal p12e cleavage site after the 39
ubgenomic promoter. This vector was made by taking a
glII–SmaI fragment containing the subgenomic pro-
oter and lacZ from pSFVlacZ (Life Technologies, Gaith-
rsburg, MD), converting the SmaI site to BglII with a
linker, and inserting this fragment into pSFVMenv-tr (Leb-
edeva et al., 1997) cut with BglII (Fig. 1, second line).
pMLVenv12 is a stable expression vector for
MLVenv12e that was derived from pABWN (Niwa et al.,
1991), a plasmid containing a TK promoter driving the
neomycin resistance gene, followed by a hybrid CMV-IE-
enhancer/chicken actin promoter upstream of a multi-
cloning site. We began with a derivative of pABWN,
pCD4Fed (Matano et al., 1995), that was kindly provided
by Tetsuro Matano (AIDS Research Center, National In-
stitute of Infectious Diseases, Tokyo, Japan). pCD4Fed
contains, in the multicloning site of pABWN, the human
CD4 gene fused to F-MLVenv with a stop codon at the
normal p12e cleavage site. We digested pCD4Fed with
XbaI and ClaI to remove CD4 and F-MLV env sequences
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131CHANGES IN A RETROVIRAL RECEPTOR DURING PASSAGEup to a ClaI site just upstream of the p12e stop codon. An
XbaI–ClaI fragment containing M-MLV env sequence
from the initiation codon to the homologous ClaI site was
then inserted. The resulting expression vector for fuso-
genic MLVenv is designated pMLVenv12 (Fig. 1, third
line).
Cells
BHK cells (American Type Culture Collection, Gaith-
ersburg, MD) and NIH3T3 cells (Janet Hartley, National
Institutes of Health, Bethesda, MD) were grown in
DMEM (Life Technologies) supplemented with 10% FCS.
NIH3T3 cells chronically infected with M-MLV are des-
ignated M-MLV-NIH3T3. BHK cells stably expressing
MLVenv with a stop codon at the normal p12e cleavage
site were obtained through transfection with plasmid
pMLVenv12 and selection with 0.4–0.8 mg/ml G418 (Life
Technologies). Colonies were screened for expression of
MLVenv by flow cytometry using goat anti-Rauscher MLV
env serum (National Cancer Institute, Bethesda, MD).
One such cell line is designated BHK-MLVenv12.
Vector RNA and electroporation
Approximately 1 mg of PacI-linearized Sindbis plasmid
NA was transcribed in vitro using SP6 RNA polymerase
Promega, Madison WI) and 7-methyl-G (New England
ioLabs, Beverly, MA). The transcription mixture was
dded to 106–7 BHK cells in 0.4 ml of PBS and pulsed
wice using a Bio-Rad (Hercules, CA) electroporation
evice set to 0.8–1.2 kV and 25 mF.
Infection and plaque assay
Cell lysates were made by suspending cells harvested
with a rubber policeman in 1 ml of DMEM and breaking
them open with a Dounce homogenizer (50 strokes) or by
vigorous shaking with 0.5-mm glass beads in a
MiniBeadbeater (Biospec Products, Bartlesville, OK) or
through ultrasonification for 30 s in a Torbeo Ultrasonic
Cell Disruptor (Cole-Parmer Instrument Co., Vernon Hills,
IL). Cell lysates or supernatants were passed through
0.45-mm filters. BHK-MLVenv12 cells were infected when
70% confluent by incubation with 0.5–1 ml of filtered
ell lysate or supernatant in DMEM–1% FCS supple-
ented with 8 mg/ml Polybrene. After 4 h, the inoculum
was replaced with DMEM–1% FCS, and the cells were
fixed and stained 24–48 h later with methanol containing
0.17% (wt/vol) carbol Fuchsin and 0.5% methylene blue.
Syncytia were counted under a dissecting microscope.
RT-PCR and assays for Tsp509I and BstUI restriction
site polymorphisms in mCAT1
RNA from infected cells was prepared using Trizol
(Life Technologies) and amplified with a Titan RT-PCR kit
(Boehringer Mannheim, Indianapolis, IN). For RT-PCR of Kthe full-length mCAT1 gene in Sindbis vector RNA, we
used reverse primer 59-ACCAGCCTGATGCATTATGC and
forward primer 59-CTACGGTGGTCCTAAATAGTCAGC,
which correspond to sequences in the 39 untranslated
egion and subgenomic promoter flanking mCAT1 in
SINRep5. To amplify a 430-bp segment containing the
hird extracellular loop of mCAT1 (bases 399–828), we
sed reverse primer 59-CTGGGGGTTCTTGACTTCTTCC
nd forward primer 59-TGCGACTTTTGACGAGCTGATAG.
his PCR product was digested with Tsp509I, which cuts
t positions 513, 573, and 667 in the wild-type mCAT1
equence, or with BstUI, and the digestion products
ere electrophoresed in 6% acrylamide gels.
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